{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:49:52Z","timestamp":1782190192701,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:00:00Z","timestamp":1348185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T00:00:00Z","timestamp":1348185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s11030-012-9394-x","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T10:36:44Z","timestamp":1348137404000},"page":"803-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors"],"prefix":"10.1007","volume":"16","author":[{"given":"Pran Kishore","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Piplani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuram Rao","family":"Akkinepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,21]]},"reference":[{"key":"9394_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ddr.10081","volume":"56","author":"DK Lahiri","year":"2002","unstructured":"Lahiri DK, Farlow MR, Greig NH, Sambamurti K (2002) Current drug targets for Alzheimer\u2019s disease treatment. Drug Dev Res 56: 267\u2013281. doi:10.1002\/ddr.10081","journal-title":"Drug Dev Res"},{"key":"9394_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","volume":"275","author":"NC Inestrosa","year":"2008","unstructured":"Inestrosa NC, Dinamarca MC, Alvarez A (2008) Amyloid\u2013cholinesterase interactions. Implications for Alzheimer\u2019s disease. FEBS J 275: 625\u2013632. doi:10.1111\/j.1742-4658.2007.06238.x","journal-title":"FEBS J"},{"key":"9394_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362: 329\u2013344. doi:10.1056\/NEJMra0909142","journal-title":"N Engl J Med"},{"key":"9394_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/156720509787602861","volume":"6","author":"G Pepeu","year":"2009","unstructured":"Pepeu G, Giovannini MG (2009) Cholinesterase inhibitors and beyond. Curr Alzheimer Res 6: 86\u201396. doi:10.2174\/156720509787602861","journal-title":"Curr Alzheimer Res"},{"key":"9394_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2146\/ajhp070622","volume":"66","author":"DA Smith","year":"2009","unstructured":"Smith DA (2009) Treatment of Alzheimer\u2019s disease in the long-term care setting. Am J Health Syst Pharm 66: 899\u2013907. doi:10.2146\/ajhp070622","journal-title":"Am J Health Syst Pharm"},{"key":"9394_CR6","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1038\/399a023","volume":"399","author":"DJ Selkoe","year":"1999","unstructured":"Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer\u2019s disease. Nature 399: A23\u2013A31. doi:10.1038\/399a023","journal-title":"Nature"},{"key":"9394_CR7","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1021\/jm901853b","volume":"53","author":"E Carletti","year":"2010","unstructured":"Carletti E, Colletier JP, Dupeux F, Trovaslet M, Masson P, Nachon F (2010) Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation. J Med Chem 53: 4002\u20134008. doi:10.1021\/jm901853b","journal-title":"J Med Chem"},{"key":"9394_CR8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1107\/S0907444900010659","volume":"56","author":"G Kryger","year":"2000","unstructured":"Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel N, Shafferman A, Silman I, Sussman JL (2000) Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D 56: 1385\u20131394. doi:10.1107\/S0907444900010659","journal-title":"Acta Crystallogr D"},{"key":"9394_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","volume":"7","author":"G Kryger","year":"1999","unstructured":"Kryger G, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 7: 297\u2013307. doi:10.1016\/S0969-2126(99)80040-9","journal-title":"Structure"},{"key":"9394_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nsb0197-57","volume":"4","author":"ML Raves","year":"1997","unstructured":"Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL (1997) Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat Struct Biol 4: 57\u201363. doi:10.1038\/nsb0197-57","journal-title":"Nat Struct Biol"},{"key":"9394_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","volume":"463","author":"HM Greenblatt","year":"1999","unstructured":"Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 \u00c5 resolution. FEBS Lett 463: 321\u2013326. doi:10.1016\/S0014-5793(99)01637-3","journal-title":"FEBS Lett"},{"key":"9394_CR12","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1073\/pnas.90.19.9031","volume":"90","author":"M Harel","year":"1993","unstructured":"Harel M, Schalk I, Ehret-sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 90: 9031\u20139035. doi:10.1073\/pnas.90.19.9031","journal-title":"Proc Natl Acad Sci USA"},{"key":"9394_CR13","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1021\/jm010826r","volume":"44","author":"C Doucet-Personeni","year":"2001","unstructured":"Doucet-Personeni C, Bentley PD, Fletcher RJ, Kinkaid A, Kryger G, Pirard B, Taylor A, Taylor R, Taylor J, Viner R, Silman I, Sussman JL, Greenblatt HM, Lewis T (2001) A structure-based design approach to the development of novel, reversible AChE inhibitors. J Med Chem 44: 3203\u20133215. doi:10.1021\/jm010826r","journal-title":"J Med Chem"},{"key":"9394_CR14","doi-asserted-by":"publisher","first-page":"9883","DOI":"10.1021\/ja992704i","volume":"121","author":"CB Millard","year":"1999","unstructured":"Millard CB, Koellner G, Ordentlich A, Shafferman A, Silman I, Sussman JL (1999) Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J Am Chem Soc 121: 9883\u20139884. doi:10.1021\/ja992704i","journal-title":"J Am Chem Soc"},{"key":"9394_CR15","doi-asserted-by":"publisher","first-page":"15405","DOI":"10.1021\/ja0466154","volume":"126","author":"HM Greenblatt","year":"2004","unstructured":"Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti S, Badet B, Thal C, Silman I, Sussman JL (2004) The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design. J Am Chem Soc 126: 15405\u201315411. doi:10.1021\/ja0466154","journal-title":"J Am Chem Soc"},{"key":"9394_CR16","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1021\/jm060164b","volume":"49","author":"EH Rydberg","year":"2006","unstructured":"Rydberg EH, Brumshtein B, Greenblatt HM, Wong DM, Shaya D, Williams LD, Carlier PR, Pang YP, Silman I, Sussman JL (2006) Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of bis(5)-tacrine produces a dramatic rearrangement in the active-site gorge. J Med Chem 49: 5491\u20135500. doi:10.1021\/jm060164b","journal-title":"J Med Chem"},{"key":"9394_CR17","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/ja952232h","volume":"118","author":"M Harel","year":"1996","unstructured":"Harel M, Quinn DM, Nair HK, Silman I, Sussman JL (1996) The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. J Am Chem Soc 118: 2340\u20132346. doi:10.1021\/ja952232h","journal-title":"J Am Chem Soc"},{"key":"9394_CR18","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1107\/S0907444998005277","volume":"1","author":"RB Ravelli","year":"1998","unstructured":"Ravelli RB, Raves ML, Ren Z, Bourgeois D, Roth M, Kroon J, Silman I, Sussman JL (1998) Static Laue diffraction studies on acetylcholinesterase. Acta Crystallogr D 1: 1359\u20131366. doi:10.1107\/S0907444998005277","journal-title":"Acta Crystallogr D"},{"key":"9394_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1678899","volume":"253","author":"JL Sussman","year":"1991","unstructured":"Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253: 872\u2013879. doi:10.1126\/science.1678899","journal-title":"Science"},{"key":"9394_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cbi.2008.05.035","volume":"175","author":"I Silman","year":"2008","unstructured":"Silman I, Sussman JL (2008) Acetylcholinesterase: How is structure related to function. Chem Biol Interact 175: 3\u201310. doi:10.1016\/j.cbi.2008.05.035","journal-title":"Chem Biol Interact"},{"key":"9394_CR21","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0002-9440(10)63774-1","volume":"164","author":"AE Reyes","year":"2004","unstructured":"Reyes AE, Chacon MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC (2004) Acetylcholinesterase-A\u03b2 complexes are more toxic than A\u03b2 fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 164: 2163\u20132174. doi:10.1016\/S0002-9440(10)63774-1","journal-title":"Am J Pathol"},{"key":"9394_CR22","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.2174\/138161206778792985","volume":"12","author":"A Castro","year":"2006","unstructured":"Castro A, Mart\u0131nez A (2006) Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Curr Pharm Des 12: 4377\u20134387. doi:10.2174\/138161206778792985","journal-title":"Curr Pharm Des"},{"key":"9394_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","volume":"65","author":"M Bartolini","year":"2003","unstructured":"Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) \u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65: 407\u2013416. doi:10.1016\/S0006-2952(02)01514-9","journal-title":"Biochem Pharmacol"},{"key":"9394_CR24","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1021\/jm049695v","volume":"47","author":"J Guo","year":"2004","unstructured":"Guo J, Hurley MM, Wright JB, Lushington GH (2004) A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition. J Med Chem 47: 5492\u20135500. doi:10.1021\/jm049695v","journal-title":"J Med Chem"},{"key":"9394_CR25","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1016\/j.bmcl.2006.09.030","volume":"16","author":"A Nagaraju","year":"2006","unstructured":"Nagaraju A, Laurent L, Janet G, Vassilios P (2006) 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Bioorg Med Chem Lett 16: 6277\u20136280. doi:10.1016\/j.bmcl.2006.09.030","journal-title":"Bioorg Med Chem Lett"},{"key":"9394_CR26","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1021\/jm100573q","volume":"53","author":"SS Chaudhary","year":"2010","unstructured":"Chaudhary SS, Roy KK, Shakya N, Saxena G, Sammi SR, Nazir A, Nath C, Saxena AK (2010) Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology. J Med Chem 53: 6490\u20136505. doi:10.1021\/jm100573q","journal-title":"J Med Chem"},{"key":"9394_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1021\/ci900491t","volume":"50","author":"JSO Santos","year":"2010","unstructured":"Santos JSO, Lesnard A, Agondanou JH, Dupont N, Godard AM, Stiebing S, Rochais C, Fabis F, Dallemagne P, Bureau R, Rault S (2010) Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library. J Chem Inf Model 50: 422\u2013428. doi:10.1021\/ci900491t","journal-title":"J Chem Inf Model"},{"key":"9394_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s00044-010-9373-7","volume":"20","author":"S Gupta","year":"2011","unstructured":"Gupta S, Mohan CG (2011) 3D-pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors. Med Chem Res 20: 1422\u20131430. doi:10.1007\/s00044-010-9373-7","journal-title":"Med Chem Res"},{"key":"9394_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1747-0285.2011.01277.x","volume":"79","author":"B Lakshmi Narayana","year":"2012","unstructured":"Lakshmi Narayana B, Pran Kishore D, Balakumar C, Venkata Rao K, Rajwinder K, Raghuram Rao A, Narashima Murthy J, Ravikumar M (2012) Molecular modeling evaluation of non-steroidal aromatase inhibitors. Chem Biol Drug Des 79: 674\u2013682. doi:10.1111\/j.1747-0285.2011.01277.x","journal-title":"Chem Biol Drug Des"},{"key":"9394_CR30","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1021\/jm100329q","volume":"53","author":"MI Fernandez-Bachiller","year":"2010","unstructured":"Fernandez-Bachiller MI, Perez C, Gonzalez-Munoz GC, Conde S, Lopez MG, Villarroya M, Garc\u0131a AG, Rodriguez-Franco MI (2010) Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of alzheimer\u2019s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J Med Chem 53: 4927\u20134937. doi:10.1021\/jm100329q","journal-title":"J Med Chem"},{"key":"9394_CR31","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1021\/jm801292b","volume":"52","author":"J Marco-Contelles","year":"2009","unstructured":"Marco-Contelles J, Leon R, de los Rios C, Samadi A, Bartolini M, Andrisano V, Huertas O, Barril X, Luque FJ, Rodr\u0131guez-Franco MI, Lopez B, Lopez MG, Garc\u0131a AG, Carreiras MC, Villarroya M (2009) Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease. J Med Chem 52: 2724\u20132732. doi:10.1021\/jm801292b","journal-title":"J Med Chem"},{"key":"9394_CR32","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1021\/jm8001313","volume":"51","author":"P Camps","year":"2008","unstructured":"Camps P, Formosa X, Galdeano C, Gomez T, Munoz-Torrero D, Scarpellini M, Viayna E, Badia A, Victoria-Clos M, Camins A, Pallas M, Bartolini M, Mancini F, Andrisano V, Estelrich J, Lizondo M, Bidon-Chanal A, Luque FJ (2008) Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced \u03b2-amyloid aggregation. J Med Chem 51: 3588\u20133598. doi:10.1021\/jm8001313","journal-title":"J Med Chem"},{"key":"9394_CR33","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1021\/jm800577j","volume":"51","author":"M Rosini","year":"2008","unstructured":"Rosini M, Simoni E, Bartolini M, Cavalli A, Ceccarini L, Pascu N, McClymont DW, Tarozzi A, Bolognesi ML, Minarini A, Tumiatti V, Andrisano V, Mellor IR, Melchiorre C (2008) Inhibition of acetylcholinesterase, \u03b2-amyloid aggregation and NMDA receptors in alzheimer\u2019s disease: a promising direction for the multi-target-directed ligands gold rush. J Med Chem 51: 4381\u20134384. doi:10.1021\/jm800577j","journal-title":"J Med Chem"},{"key":"9394_CR34","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1021\/jm8002747","volume":"51","author":"S Rizzo","year":"2008","unstructured":"Rizzo S, Riviere C, Piazzi L, Bisi A, Gobbi S, Bartolini M, Andrisano V, Morroni F, Tarozzi A, Monti JP, Rampa A (2008) Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, \u03b2-amyloid aggregation, and A\u03b2 neurotoxicity. J Med Chem 51: 2883\u20132886. doi:10.1021\/jm8002747","journal-title":"J Med Chem"},{"key":"9394_CR35","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1021\/jm049782n","volume":"47","author":"ML Bolognesi","year":"2004","unstructured":"Bolognesi ML, Bartolini M, Cavalli A, Andrisano V, Rosini M, Minarini A, Melchiorre C (2004) Design, synthesis and biological evaluation of conformationally restricted rivastigmine analogues. J Med Chem 47: 5945\u20135952. doi:10.1021\/jm049782n","journal-title":"J Med Chem"},{"key":"9394_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/jm050746d","volume":"49","author":"MI Rodr\u0131guez-Franco","year":"2006","unstructured":"Rodr\u0131guez-Franco MI, Fernandez-Bachiller MI, Perez C, Hernandez-Ledesma B, Bartolome B (2006) Novel tacrine-melatonin hybrids as dual-acting drugs for alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties. J Med Chem 49: 459\u2013462. doi:10.1021\/jm050746d","journal-title":"J Med Chem"},{"key":"9394_CR37","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1021\/jm050578p","volume":"49","author":"W Luo","year":"2006","unstructured":"Luo W, Yu QS, Kulkarni SS, Parrish DA, Holloway HW, Tweedie D, Shafferman A, Lahiri DK, Brossi A, Greig NH (2006) Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine. J Med Chem 49: 2174\u20132185. doi:10.1021\/jm050578p","journal-title":"J Med Chem"},{"key":"9394_CR38","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.1021\/jm8009684","volume":"51","author":"V Tumiatti","year":"2008","unstructured":"Tumiatti V, Milelli A, Minarini A, Rosini M, Bolognesi ML, Micco M, Andrisano V, Bartolini M, Mancini F, Recanatini M, Cavalli A, Melchiorre C (2008) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer. J Med Chem 51: 7308\u20137312. doi:10.1021\/jm8009684","journal-title":"J Med Chem"},{"key":"9394_CR39","unstructured":"GLIDE Maestro, version 9.1 (2010) Schrodinger, LLC, New York"},{"key":"9394_CR40","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47: 1739\u20131749. doi:10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"9394_CR41","unstructured":"GOLD, version 4.0 (2000) Cambridge Crystallographic Data Centre, Cambridge"},{"key":"9394_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Talor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267: 727\u2013748. doi:10.1006\/jmbi.1996.0897","journal-title":"J Mol Biol"},{"key":"9394_CR43","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1023\/A:1007996124545","volume":"11","author":"MD Eldridge","year":"1997","unstructured":"Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) Empirical scoring functions: I. the development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 11: 425\u2013445. doi:10.1023\/A:1007996124545","journal-title":"J Comput Aided Mol Des"},{"key":"9394_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/prot.20588","volume":"61","author":"WTM Mooij","year":"2005","unstructured":"Mooij WTM, Verdonk ML (2005) General and targeted statistical potentials for protein\u2013ligand interactions. Proteins 61: 272\u2013287. doi:10.1002\/prot.20588","journal-title":"Proteins"},{"key":"9394_CR45","unstructured":"LIGANDFIT, Discovery Studio Modeling Environment Release, version 2.1 (2008) Accelrys Software Inc, San Diego"},{"key":"9394_CR46","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1021\/jm050038s","volume":"49","author":"I Muegge","year":"2006","unstructured":"Muegge I (2006) PMF scoring revisited. J Med Chem 49: 5895\u20135902. doi:10.1021\/jm050038s","journal-title":"J Med Chem"},{"key":"9394_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","volume":"2","author":"DK Gehlhaar","year":"1995","unstructured":"Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, Freer ST (1995) Molecular recognition of the inhibitor AG-1343 by HIV-1 Protease: conformationally flexible docking by evolutionary programming. Chem Biol 2: 317\u2013324. doi:10.1016\/1074-5521(95)90050-0","journal-title":"Chem Biol"},{"key":"9394_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2174\/138920306778559395","volume":"7","author":"NJ Ajay","year":"2006","unstructured":"Ajay NJ (2006) Scoring functions for protein-ligand docking. Curr Protein Pept Sci 7: 407\u2013420. doi:10.2174\/138920306778559395","journal-title":"Curr Protein Pept Sci"},{"key":"9394_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jmgm.2004.11.007","volume":"23","author":"A Krammer","year":"2005","unstructured":"Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M (2005) LigScore: a novel scoring function for predicting binding affinities. J Mol Graph Model 23: 395\u2013407. doi:10.1016\/j.jmgm.2004.11.007","journal-title":"J Mol Graph Model"},{"key":"9394_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcc.540130412","volume":"13","author":"EC Meng","year":"1992","unstructured":"Meng EC, Shoichet BK, Kuntz ID (1992) Automated docking with grid-based energy evaluation. J Comput Chem 13: 505\u2013524. doi:10.1002\/jcc.540130412","journal-title":"J Comput Chem"},{"key":"9394_CR51","unstructured":"MacroModel, version 9.8 (2010) Schr\u00f6dinger, LLC, New York"},{"key":"9394_CR52","unstructured":"QikProp, version 3.3 (2010) Schr\u00f6dinger, LLC, New York"},{"key":"9394_CR53","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1186\/1752-153X-2-S1-P9","volume":"2","author":"K Roy","year":"2007","unstructured":"Roy K (2007) On some aspects of validation of predictive quantitative structure-activity relationship models. Expert Opin Drug Discov 2: 1567\u20131577. doi:10.1186\/1752-153X-2-S1-P9","journal-title":"Expert Opin Drug Discov"},{"key":"9394_CR54","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bmcl.2010.11.094","volume":"21","author":"PK Deb","year":"2011","unstructured":"Deb PK, Balakumar C, Rao AR, Roy PP, Roy K (2011) QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A\n3 receptor subtype. Bioorg Med Chem Lett 21: 818\u2013823. doi:10.1016\/j.bmcl.2010.11.094","journal-title":"Bioorg Med Chem Lett"},{"key":"9394_CR55","volume-title":"Cluster analysis","author":"BS Everitt","year":"2001","unstructured":"Everitt BS, Landau S, Leese M (2001) Cluster analysis. Arnold, London"},{"key":"9394_CR56","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/qsar.200710043","volume":"27","author":"PP Roy","year":"2008","unstructured":"Roy PP, Roy K (2008) On some aspects of variable selection for partial least squares regression models. QSAR Comb Sci 27: 302\u2013313. doi:10.1002\/qsar.200710043","journal-title":"QSAR Comb Sci"},{"key":"9394_CR57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/qsar.200810130","volume":"28","author":"K Roy","year":"2009","unstructured":"Roy K, Paul S (2009) Exploring 2D and 3D QSARs of 2,4-Diphenyl-1,3-oxazolines for Ovicidal Activity Against Tetranychus urticae. QSAR Comb Sci 28: 406\u2013425. doi:10.1002\/qsar.200810130","journal-title":"QSAR Comb Sci"},{"key":"9394_CR58","volume-title":"Regression and linear models","author":"RB Darlington","year":"1990","unstructured":"Darlington RB (1990) Regression and linear models. McGraw-Hill, New York"},{"key":"9394_CR59","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1747-0285.2009.00801.x","volume":"73","author":"I Mitra","year":"2009","unstructured":"Mitra I, Saa A, Roy K (2009) Quantitative structure\u2013activity relationship modeling of antioxidant activities of hydroxybenzalacetones using quantum chemical, physicochemical and spatial descriptors. Chem Biol Drug Des 73: 526\u2013536. doi:10.1111\/j.1747-0285.2009.00801.x","journal-title":"Chem Biol Drug Des"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-012-9394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-012-9394-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-012-9394-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-012-9394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T04:42:31Z","timestamp":1614832951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-012-9394-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,21]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9394"],"URL":"https:\/\/doi.org\/10.1007\/s11030-012-9394-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,21]]},"assertion":[{"value":"13 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}